COMMUNIQUÉS West-GlobeNewswire

Burcon Congratulates Protein Industries Canada

20/02/2018 - 14:35

VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Corporation”), a leader in natural product extraction, purification and [...]

In Midst of Flu Epidemic, Teladoc Provides Relief for Overburdened Health System

20/02/2018 - 14:35

PURCHASE, NY, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the world’s largest and most trusted provider of virtual care delivery services, announced today that amid the most severe flu outbreak in a [...]

Xenon Pharmaceuticals Advances Second Proprietary Epilepsy Product into the Clinic with Initiation of XEN901 Phase 1 Clinical Trial

20/02/2018 - 14:30

BURNABY, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today announced the initiation of a Phase 1 clinical trial of its [...]

Onconova Announces Two Presentations at 2018 American Chemical Society National Meeting and Expo

20/02/2018 - 14:30

Product stability studies for rigosertib, a Phase 3 clinical stage product in development for Myelodysplastic Syndromes (MDS) Discovery of a novel kinase inhibitor, ON 150030, a Type 1 inhibitor of FLT3 and Src for [...]

Marrone Bio Innovations Announces The Netherlands as New Rapporteur Member State for Sakalia

20/02/2018 - 14:30

DAVIS, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]

Histogenics Corporation to Present at Upcoming Investor Conferences

20/02/2018 - 14:30

WALTHAM, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]

Acology’s Perfect Package: MedTainer Confirmed Compliant for US, Canada and Mexico

20/02/2018 - 14:30

CORONA, Calif, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) confirmed today that its signature product, the MedTainer™, is compliant for the entire North American market, and specifically for the [...]

Nuvectra Secures $45 Million Second Amendment to Existing Loan and Security Agreement

20/02/2018 - 14:30

PLANO, Texas, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that it has reached an agreement with Silicon Valley Bank and Oxford [...]

Athenex Announces Phase II Clinical Study Results for KX2-391 Ointment for the Treatment of Actinic Keratosis in the American Academy of Dermatology Meeting

20/02/2018 - 14:11

BUFFALO, N.Y., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Athenex (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer [...]

Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director

20/02/2018 - 14:00

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of directors effective [...]

T2 Biosystems Announces 2017 Fourth Quarter and Full-Year Financial and Operational Results Release and Conference Call Date

20/02/2018 - 14:00

LEXINGTON, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]

AveXis to Report Fourth Quarter and Full Year 2017 Financial and Operating Results

20/02/2018 - 14:00

CHICAGO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]

AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast on Tuesday, February 27, 2018 at 8:00 a.m. ET

20/02/2018 - 14:00

WALTHAM, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that its fourth quarter and full year 2017 financial results will be released on Tuesday, February 27, 2018 [...]

PositiveID to Exhibit its Caregiver Non-Contact Thermometer at EMS Today, a Journal of Emergency Medical Services Conference and Exposition, February 21-23

20/02/2018 - 14:00

DELRAY BEACH, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that its Thermomedics subsidiary will exhibit the [...]

resTORbio to Present at the 2018 RBC Capital Markets Global Healthcare Conference

20/02/2018 - 14:00

BOSTON, Feb. 20, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging- [...]

3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL™ Test for Hodgkin’s Lymphoma

20/02/2018 - 14:00

TORONTO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD ) (OTCQB:TDSGF) (FSE:3D0) (the " Company " or " 3DS ") is pleased to announce that a preliminary third-party analysis of the trial data for [...]

Premier Biomedical Pain Relief Products Now Sold Through Okeechobee Discount Drugs

20/02/2018 - 14:00

JACKSON CENTER, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) announced today they have signed a distribution agreement with Okeechobee Discount Drugs to sell and distribute Premier’s pain [...]

CAR T-Cell Therapy Platform

20/02/2018 - 14:00

SAN DIEGO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

Menlo Therapeutics’ Phase 2 Serlopitant Study for the Treatment of Chronic Pruritus Published in the Journal of the American Academy of Dermatology

20/02/2018 - 14:00

REDWOOD CITY, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused on the development of serlopitant, for the treatment of pruritus associated [...]